Identification of an AAA ATPase VPS4B-dependent pathway that modulates epidermal growth factor receptor abundance and signaling during hypoxia

Molecular and Cellular Biology

Volumn 32, Issue 6, 2012, Pages 1124-1138

  Lin, H Helen ^a   Li, Xu ^a   Chen, Jo Lin ^a   Sun, Xiuzhu ^a   Cooper, Fariba Norouziyan ^a   Chen, Yun Ru ^a   Zhang, Wenyu ^a   Chung, Yiyin ^a   Li, Angela ^a   Cheng, Chun Ting ^a   Yang, Lixin ^a   Deng, XuTao ^a   Liu, Xiyong ^a   Yen, Yun ^a   Johnson, Deborah L ^b   Shih, Hsiu Ming ^c   Yang, Austin ^d   Ann, David K ^a  

^a CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^c INSTITUTE OF BIOMEDICAL SCIENCES   (Taiwan)

^d UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1,4 DIAMINO 1,4 BIS(2 AMINOPHENYLTHIO) 2,3 DICYANOBUTADIENE; ADENOSINE TRIPHOSPHATASE; EPIDERMAL GROWTH FACTOR RECEPTOR 3; GEFITINIB; UBIQUITIN; UNCLASSIFIED DRUG; VPS4B PROTEIN;

ANIMAL CELL; ARTICLE; BREAST CANCER; CANCER CELL; CANCER GROWTH; CANCER RESISTANCE; CELL COMPARTMENTALIZATION; CELL CULTURE; CELL HYPOXIA; CELL PROLIFERATION; CELL SURVIVAL; CONTROLLED STUDY; GENOTOXICITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEPLETION; PROTEIN EXPRESSION; RAT; RECEPTOR DOWN REGULATION; TUMOR GROWTH;

ADENOSINE TRIPHOSPHATASES; ANIMALS; BREAST NEOPLASMS; CELL HYPOXIA; CELL LINE; CELL LINE, TUMOR; DOWN-REGULATION; ENDOSOMAL SORTING COMPLEXES REQUIRED FOR TRANSPORT; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; PHOSPHORYLATION; RATS; RECEPTOR, EPIDERMAL GROWTH FACTOR; RNA, MESSENGER; SIGNAL TRANSDUCTION; SPHEROIDS, CELLULAR;

MAMMALIA;

EID: 84863298470     PISSN: 02707306     EISSN: 10985549     Source Type: Journal    
DOI: 10.1128/MCB.06053-11     Document Type: Article

References (69)

1. Bache KG, Slagsvold T, Stenmark H. 2004. Defective downregulation of receptor tyrosine kinases in cancer. EMBO J. 23:2707-2712.
2. Bache KG, et al. 2006. The ESCRT-III subunit hVps24 is required for degradation but not silencing of the epidermal growth factor receptor. Mol. Biol. Cell 17:2513-2523.
3. Bjorkoy G, et al. 2005. p62/SQSTM1 forms protein aggregates degraded by autophagy and has a protective effect on huntingtin-induced cell death. J. Cell Biol. 171:603-614.
4. Bjorkoy G, Lamark T, Johansen T. 2006. p62/SQSTM1: a missing link between protein aggregates and the autophagy machinery. Autophagy 2:138-139.
5. Brahimi-Horn MC, Bellot G, Pouyssegur J. 2011. Hypoxia and energetic tumour metabolism. Curr. Opin. Genet. Dev. 21:67-72.
6. Buchberger A, Bukau B, Sommer T. 2010. Protein quality control in the cytosol and the endoplasmic reticulum: brothers in arms. Mol. Cell 40:238-252.
7. Burke P, Schooler K, Wiley HS. 2001. Regulation of epidermal growth factor receptor signaling by endocytosis and intracellular trafficking. Mol. Biol. Cell 12:1897-1910.
8. Cao N, et al. 2009. NF-κB-mediated HER2 overexpression in radiationadaptive resistance. Radiat. Res. 171:9-21.
9. Chen JL, et al. 2008. Novel roles for protein kinase Cδ-dependent signaling pathways in acute hypoxic stress-induced autophagy. J. Biol. Chem. 283:34432-34444.
10. Chen JL, et al. 2009. PKC delta signaling: a dual role in regulating hypoxic stress-induced autophagy and apoptosis. Autophagy 5:244-246.
11. Clavijo C, Chen JL, Kim KJ, Reyland ME, Ann DK. 2007. Protein kinase Cδ-dependent and -independent signaling in genotoxic response to treatment of desferroxamine, a hypoxia-mimetic agent. Am. J. Physiol. Cell Physiol. 292:C2150 -C2160.
12. Esclatine A, Chaumorcel M, Codogno P. 2009. Macroautophagy signaling and regulation. Curr. Top. Microbiol. Immunol. 335:33-70.
13. Fader CM, Colombo MI. 2009. Autophagy and multivesicular bodies: two closely related partners. Cell Death Differ. 16:70-78.
14. Filimonenko M, et al. 2007. Functional multivesicular bodies are required for autophagic clearance of protein aggregates associated with neurodegenerative disease. J. Cell Biol. 179:485-500.
15. Franovic A, et al. 2007. Translational up-regulation of the EGFR by tumor hypoxia provides a nonmutational explanation for its overexpression in human cancer. Proc. Natl. Acad. Sci. U. S. A. 104:13092-13097.
16. Golding SE, et al. 2009. Pro-survival AKT and ERK signaling from EGFR and mutant EGFRvIII enhances DNA double-strand break repair in human glioma cells. Cancer Biol. Ther. 8:730-738.
17. Hoffmann E, et al. 2008. Transcriptional regulation of EGR-1 by the interleukin-1-JNK-MKK7-c-Jun pathway. J. Biol. Chem. 283:12120-12128.
18. Huang HS, et al. 1997. The enhanced tumorigenic activity of a mutant epidermal growth factor receptor common in human cancers is mediated by threshold levels of constitutive tyrosine phosphorylation and unattenuated signaling. J. Biol. Chem. 272:2927-2935.
19. Huang PH, Xu AM, White FM. 2009. Oncogenic EGFR signaling networks in glioma. Sci. Signal. 2:re6.
20. Ivshina AV, et al. 2006. Genetic reclassification of histologic grade delineates new clinical subtypes of breast cancer. Cancer Res. 66:10292-10301.
21. Katzmann DJ, Odorizzi G, Emr SD. 2002. Receptor downregulation and multivesicular-body sorting. Nat. Rev. Mol. Cell Biol. 3:893-905.
22. Klionsky DJ, Elazar Z, Seglen PO, Rubinsztein DC. 2008. Does bafilomycin A(1) block the fusion of autophagosomes with lysosomes? Autophagy 4:849-950.
23. Klionsky DJ, Emr SD. 2000. Autophagy as a regulated pathway of cellular degradation. Science 290:1717-1721.
24. Leek RD, Stratford I, Harris AL. 2005. The role of hypoxia-inducible factor-1 in three-dimensional tumor growth, apoptosis, and regulation by the insulin-signaling pathway. Cancer Res. 65:4147-4152.
25. Lenferink AE, et al. 1998. Differential endocytic routing of homo- and hetero-dimeric ErbB tyrosine kinases confers signaling superiority to receptor heterodimers. EMBO J. 17:3385-3397.
26. Li L, Cohen SN. 1996. Tsg101: a novel tumor susceptibility gene isolated by controlled homozygous functional knockout of allelic loci in mammalian cells. Cell 85:319-329.
27. Liang C, et al. 2008. Beclin1-binding UVRAG targets the class C Vps complex to coordinate autophagosome maturation and endocytic trafficking. Nat. Cell Biol. 10:776-787.
28. Lloyd TE, et al. 2002. Hrs regulates endosome membrane invagination and tyrosine kinase receptor signaling in Drosophila. Cell 108:261-269.
29. Malerod L, Stuffers S, Brech A, Stenmark H. 2007. Vps22/EAP30 in ESCRT-II mediates endosomal sorting of growth factor and chemokine receptors destined for lysosomal degradation. Traffic 8:1617-1629.
30. Matsunaga K, et al. 2009. Two Beclin 1-binding proteins, Atg14L and Rubicon, reciprocally regulate autophagy at different stages. Nat. Cell Biol. 11:385-396.
31. Mazure NM, Pouyssegur J. 2010. Hypoxia-induced autophagy: cell death or cell survival? Curr. Opin. Cell Biol. 22:177-180.
32. Metcalf D, Isaacs AM. 2010. The role of ESCRT proteins in fusion events involving lysosomes, endosomes and autophagosomes. Biochem. Soc. Trans. 38:1469-1473.
33. Moasser MM, Basso A, Averbuch SD, Rosen N. 2001. The tyrosine kinase inhibitor ZD1839 ("Iressa") inhibits HER2-driven signaling and suppresses the growth of HER2-overexpressing tumor cells. Cancer Res. 61:7184-7188.
34. Mosesson Y, Mills GB, Yarden Y. 2008. Derailed endocytosis: an emerging feature of cancer. Nat. Rev. Cancer. 8:835-850.
35. Mukherjee B, et al. 2009. EGFRvIII and DNA double-strand break repair: a molecular mechanism for radioresistance in glioblastoma. Cancer Res. 69:4252-4259.
36. Nguyen HV, et al. 2006. SUMOylation attenuates sensitivity toward hypoxia- or desferroxamine-induced injury by modulating adaptive responses in salivary epithelial cells. Am. J. Pathol. 168:1452-1463.
37. Nicholson RI, Gee JM, Harper ME. 2001. EGFR and cancer prognosis. Eur. J. Cancer 37(Suppl. 4):S9 -S15.
38. O'Reilly MS, Holmgren L, Chen C, Folkman J. 1996. Angiostatin induces and sustains dormancy of human primary tumors in mice. Nat. Med. 2:689-692.
39. Papandreou I, Lim AL, Laderoute K, Denko NC. 2008. Hypoxia signals autophagy in tumor cells via AMPK activity, independent of HIF-1, BNIP3, and BNIP3L. Cell Death Differ. 15:1572-1581.
40. Piper RC, Katzmann DJ. 2007. Biogenesis and function of multivesicular bodies. Annu. Rev. Cell Dev. Biol. 23:519-547.
41. Pursiheimo JP, Rantanen K, Heikkinen PT, Johansen T, Jaakkola PM. 2009. Hypoxia-activated autophagy accelerates degradation of SQSTM1/p62. Oncogene 28:334-344.
42. Raiborg C, Stenmark H. 2009. The ESCRT machinery in endosomal sorting of ubiquitylated membrane proteins. Nature 458:445-452.
43. Rodemann HP, Dittmann K, Toulany M. 2007. Radiation-induced EGFRsignaling and control of DNA-damage repair. Int. J. Radiat. Biol. 83:781-791.
44. Rusten TE, et al. 2007. ESCRTs and Fab1 regulate distinct steps of autophagy. Curr. Biol. 17:1817-1825.
45. Sahu R, et al. 2011. Microautophagy of cytosolic proteins by late endosomes. Dev. Cell 20:131-139.
46. Saksena S, Wahlman J, Teis D, Johnson AE, Emr SD. 2009. Functional reconstitution of ESCRT-III assembly and disassembly. Cell 136:97-109.
47. Santarius T, Shipley J, Brewer D, Stratton MR, Cooper CS. 2010. A census of amplified and overexpressed human cancer genes. Nat. Rev. Cancer 10:59-64.
48. Scheuring S, et al. 2001. Mammalian cells express two VPS4 proteins both of which are involved in intracellular protein trafficking. J. Mol. Biol. 312:469-480.
49. Schlessinger J. 2000. Cell signaling by receptor tyrosine kinases. Cell 103:211-225.
50. Schmidt-Ullrich RK, Contessa JN, Lammering G, Amorino G, Lin PS. 2003. ERBB receptor tyrosine kinases and cellular radiation responses. Oncogene 22:5855-5865.
51. Shen S, et al. 2009. Cyclodepsipeptide toxin promotes the degradation of Hsp90 client proteins through chaperone-mediated autophagy. J. Cell Biol. 185:629-639.
52. Shvets E, Fass E, Elazar Z. 2008. Utilizing flow cytometry to monitor autophagy in living mammalian cells. Autophagy 4:621-628.
53. Sorkin A, Von Zastrow M. 2002. Signal transduction and endocytosis: close encounters of many kinds. Nat. Rev. Mol. Cell Biol. 3:600-614.
54. Spriggs KA, Bushell M, Willis AE. 2010. Translational regulation of gene expression during conditions of cell stress. Mol. Cell 40:228-237.
55. Stoscheck CM, Carpenter G. 1984. Down regulation of epidermal growth factor receptors: direct demonstration of receptor degradation in human fibroblasts. J. Cell Biol. 98:1048-1053.
56. Taub N, Teis D, Ebner HL, Hess MW, Huber LA. 2007. Late endosomal traffic of the epidermal growth factor receptor ensures spatial and tempo- ral fidelity of mitogen-activated protein kinase signaling. Mol. Biol. Cell 18:4698-4710.
57. Teis D, Wunderlich W, Huber LA. 2002. Localization of the MP1-MAPK scaffold complex to endosomes is mediated by p14 and required for signal transduction. Dev. Cell 3:803-814.
58. Thompson BJ, et al. 2005. Tumor suppressor properties of the ESCRT-II complex component Vps25 in Drosophila. Dev. Cell 9:711-720.
59. Vieira AV, Lamaze C, Schmid SL. 1996. Control of EGF receptor signaling by clathrin-mediated endocytosis. Science 274:2086-2089.
60. Vigneron A, Gamelin E, Coqueret O. 2008. The EGFR-STAT3 oncogenic pathway up-regulates the Eme1 endonuclease to reduce DNA damage after topoisomerase I inhibition. Cancer Res. 68:815-825.
61. Wang SC, et al. 2004. Binding at and transactivation of the COX-2 promoter by nuclear tyrosine kinase receptor ErbB-2. Cancer Cell 6:251-261.
62. Wang Y, et al. 2009. Regulation of endocytosis via the oxygen-sensing pathway. Nat. Med. 15:319-324.
63. Wang Z, Zhang L, Yeung TK, Chen X. 1999. Endocytosis deficiency of epidermal growth factor (EGF) receptor-ErbB2 heterodimers in response to EGF stimulation. Mol. Biol. Cell 10:1621-1636.
64. Webb JD, Coleman ML, Pugh CW. 2009. Hypoxia, hypoxia-inducible factors (HIF), HIF hydroxylases and oxygen sensing. Cell Mol. Life Sci. 66:3539-3554.
65. Weihua Z, et al. 2008. Survival of cancer cells is maintained by EGFR independent of its kinase activity. Cancer Cell 13:385-393.
66. White SR, Lauring B. 2007. AAA+ ATPases: achieving diversity of function with conserved machinery. Traffic 8:1657-1667.
67. Wouters BG, Koritzinsky M. 2008. Hypoxia signalling through mTOR and the unfolded protein response in cancer. Nat. Rev. Cancer 8:851-864.
68. Yoshimori T, et al. 2000. The mouse SKD1, a homologue of yeast Vps4p, is required for normal endosomal trafficking and morphology in mammalian cells. Mol. Biol. Cell 11:747-763.
69. Yuhas JM, Li AP, Martinez AO, Ladman AJ. 1977. A simplified method for production and growth of multicellular tumor spheroids. Cancer Res. 37:3639-3643.